Financial statements Vita-Med Zosin
Balance sheet data of VITA-MED ZOSIN
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 987 163,72 | 3 630 488,45 | 5 376 501,63 | 5 598 771,85 | 5 579 342,89 |
| A. Fixed assets | 661 344,58 | 3 601 414,85 | 5 304 166,60 | 5 583 944,42 | 5 545 944,38 |
| B. Current assets | 325 819,14 | 29 073,60 | 72 335,03 | 14 827,43 | 33 398,51 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 987 163,72 | 3 430 488,45 | 5 376 501,63 | 5 598 771,85 | 5 579 342,89 |
| A. Equity | -336 506,68 | 2 513 722,16 | 3 450 123,74 | 3 226 717,40 | 3 279 672,15 |
| B. Liabilities and provisions for liabilities | 1 323 670,40 | 916 766,29 | 1 926 377,89 | 2 372 054,45 | 2 299 670,74 |
| I. Long-term liabilities | 0,00 | 0,00 | 1 720 000,00 | 2 191 905,00 | 1 923 861,00 |
| II. Short-term liabilities | 1 324 507,35 | 916 766,29 | 206 377,89 | 180 149,45 | 375 809,74 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.